Patient Preferences for Breast Reconstruction After Mastectomy
2 other identifiers
observational
145
1 country
1
Brief Summary
Deciding whether or not to have breast reconstruction after mastectomy is highly challenging for many patients. This study will examine patients' decisions about reconstruction and the effects of reconstruction on quality of life and body image.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2012
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 12, 2011
CompletedFirst Posted
Study publicly available on registry
December 8, 2011
CompletedStudy Start
First participant enrolled
June 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 27, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2016
CompletedApril 26, 2017
April 1, 2017
1.7 years
October 12, 2011
April 25, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Treatment Concordance
The investigator will assess patient preferences pre-operatively using conjoint analysis. The investigator will determine if these preferences are concordant with the patient's treatment decision.
Time of Surgery decision which is an average of 2-4 weeks before surgery.
Secondary Outcomes (4)
Body Image
18 months post operatively
Satisfaction with Decisions
18 months post-operatively
Quality of Life
18 months post-operatively
Knowledge
Pre-operatively at time of decision making which is an average of 2-4 weeks before surgery.
Study Arms (1)
Early stage breast cancer patients receiving mastectomy
Eligibility Criteria
Adult women undergoing mastectomy at UNC for treatment of Stage I, II, or III breast cancer or DCIS, or for prophylaxis
You may qualify if:
- Women 21 years of age or older
- Having a mastectomy at UNC for treatment of Stage I, II, or III breast cancer, ductal carcinoma in situ (DCIS) or for prophylaxis
You may not qualify if:
- Stage IV breast cancer
- Women who do not speak English
- Severe psychiatric illness
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- UNC Lineberger Comprehensive Cancer Centerlead
- National Cancer Institute (NCI)collaborator
- North Carolina TraCS Institutecollaborator
Study Sites (1)
University of North Carolina
Chapel Hill, North Carolina, 27599, United States
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Clara N Lee, MD, MPP
Ohio State University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 12, 2011
First Posted
December 8, 2011
Study Start
June 1, 2012
Primary Completion
February 27, 2014
Study Completion
June 30, 2016
Last Updated
April 26, 2017
Record last verified: 2017-04